Portfolio company
Respiro Diagnostics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
Deep TechDigital Health
About
This company develops a breath-based liquid biopsy platform for healthcare providers to detect lung cancer and respiratory diseases through non-invasive molecular analysis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.